| Kimberly Schwartz, CRNA | |
|
30200 Telegraph Rd, Suite 220, Bingham Farms, MI 48025-4502 | |
| (248) 258-5058 | |
| Not Available |
| Full Name | Kimberly Schwartz |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 23 Years |
| Location | 30200 Telegraph Rd, Bingham Farms, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437117470 | NPI | - | NPPES |
| 104594450 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 4704231703 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Edward W Sparrow Hospital | Lansing, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Edward W Sparrow Hospital Association | 6709799166 | 522 |
News Archive
Treatment and "cure" of breast cancer doesn't ensure that the disease won't spread to the brain. Too often, sometimes years after an initial diagnosis and remission, breast cancer cells are discovered growing as new tumors within the brain. Now City of Hope researchers have found how this happens.
Nelson Laboratories announced today the expansion of its services with the addition of a dedicated Technical Consulting Services group for MedTech companies.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study of its novel once-daily oral antibiotic Restanza to treat community acquired bacterial pneumonia (CABP). The trial is the first prospectively designed superiority study to be conducted in CABP.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present updated results for a Phase 1 study of VB-111 in patients with advanced metastatic cancer at the upcoming Annual Meeting of the American Society of Clinical Oncology, taking place June 3-7, 2011, at McCormick Place in Chicago.
› Verified 9 days ago
| Entity Name | Edward W Sparrow Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366498107 PECOS PAC ID: 6709799166 Enrollment ID: O20040311001138 |
News Archive
Treatment and "cure" of breast cancer doesn't ensure that the disease won't spread to the brain. Too often, sometimes years after an initial diagnosis and remission, breast cancer cells are discovered growing as new tumors within the brain. Now City of Hope researchers have found how this happens.
Nelson Laboratories announced today the expansion of its services with the addition of a dedicated Technical Consulting Services group for MedTech companies.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study of its novel once-daily oral antibiotic Restanza to treat community acquired bacterial pneumonia (CABP). The trial is the first prospectively designed superiority study to be conducted in CABP.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present updated results for a Phase 1 study of VB-111 in patients with advanced metastatic cancer at the upcoming Annual Meeting of the American Society of Clinical Oncology, taking place June 3-7, 2011, at McCormick Place in Chicago.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly Schwartz, CRNA 319 Skyline Dr, Petoskey, MI 49770-8650 Ph: (231) 373-8781 | Kimberly Schwartz, CRNA 30200 Telegraph Rd, Suite 220, Bingham Farms, MI 48025-4502 Ph: (248) 258-5058 |
News Archive
Treatment and "cure" of breast cancer doesn't ensure that the disease won't spread to the brain. Too often, sometimes years after an initial diagnosis and remission, breast cancer cells are discovered growing as new tumors within the brain. Now City of Hope researchers have found how this happens.
Nelson Laboratories announced today the expansion of its services with the addition of a dedicated Technical Consulting Services group for MedTech companies.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, announced today that it has reached agreement with the United States Food and Drug Administration (FDA), under the Special Protocol Assessment (SPA) process, on the design of its planned Phase 3 study of its novel once-daily oral antibiotic Restanza to treat community acquired bacterial pneumonia (CABP). The trial is the first prospectively designed superiority study to be conducted in CABP.
VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that it will present updated results for a Phase 1 study of VB-111 in patients with advanced metastatic cancer at the upcoming Annual Meeting of the American Society of Clinical Oncology, taking place June 3-7, 2011, at McCormick Place in Chicago.
› Verified 9 days ago
James Bandy, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 30200 Telegraph Rd, Suite 220, Bingham Farms, MI 48025 Phone: 248-258-5058 | |
Katherine Brege-biland, CRNA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 30200 Telegraph Rd, Suite 220, Bingham Farms, MI 48025 Phone: 248-258-5058 | |
Beth Crofut, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 30200 Telegraph Rd, Suite 220, Bingham Farms, MI 48025 Phone: 248-258-5058 | |
Jane Andrea Smith, CRNA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 30200 Telegraph Rd, Suite 220, Bingham Farms, MI 48025 Phone: 313-258-5058 | |
Fernando Medina, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 30200 Telegraph Rd, Suite 220, Bingham Farms, MI 48025 Phone: 248-258-5058 | |
Jeffrey Johnson, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 30200 Telegraph Rd, Suite 220, Bingham Farms, MI 48025 Phone: 248-258-5058 | |
Marion Ozbun, CRNA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 30200 Telegraph Rd, Suite 220, Bingham Farms, MI 48025 Phone: 248-258-5058 |